Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis
Open Access
- 7 November 2005
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 6 (1)
Abstract
Background Peroxisome proliferator-activated receptor (PPAR) α, βδ and γ are nuclear receptors activated by fatty acid metabolites. An anti-inflammatory role for these receptors in airway inflammation has been suggested. Methods Nasal biopsies were obtained from 10 healthy volunteers and 10 patients with symptomatic allergic rhinitis. Nasal polyps were obtained from 22 patients, before and after 4 weeks of local steroid treatment (fluticasone). Real-time RT-PCR was used for mRNA quantification and immunohistochemistry for protein localization and quantification. Results mRNA expression of PPARα, PPARβδ, PPARγ was found in all specimens. No differences in the expression of PPARs were obtained in nasal biopsies from patients with allergic rhinitis and healthy volunteers. Nasal polyps exhibited lower levels of PPARα and PPARγ than normal nasal mucosa and these levels were, for PPARγ, further reduced following steroid treatment. PPARγ immunoreactivity was detected in the epithelium, but also found in smooth muscle of blood vessels, glandular acini and inflammatory cells. Quantitative evaluation of the epithelial immunostaining revealed no differences between nasal biopsies from patients with allergic rhinitis and healthy volunteers. In polyps, the PPARγ immunoreactivity was lower than in nasal mucosa and further decreased after steroid treatment. Conclusion The down-regulation of PPARγ, in nasal polyposis but not in turbinates during symptomatic seasonal rhinitis, suggests that PPARγ might be of importance in long standing inflammations.Keywords
This publication has 40 references indexed in Scilit:
- Peroxisome proliferator–activated receptor γ is expressed in airways and inhibits features of airway remodeling in a mouse asthma modelJournal of Allergy and Clinical Immunology, 2004
- Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular DiseaseHypertension, 2004
- Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil ActivationJournal of Experimental Medicine, 2003
- PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effectBritish Journal of Pharmacology, 2003
- Nasal polyposis: an updateCurrent Opinion in Allergy and Clinical Immunology, 2003
- Prostacyclin-dependent Apoptosis Mediated by PPARδJournal of Biological Chemistry, 2001
- Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy?Clinical & Experimental Allergy, 2001
- Peroxisome proliferator‐activated receptor γ activators inhibit interleukin‐12 production in murine dendritic cellsFEBS Letters, 2000
- Correlations between Complaints, Inflammatory Cells and Mediator Concentrations in Nasal Secretions after Nasal Allergen Challenge and during Natural Allergen ExposureInternational Archives of Allergy and Immunology, 1995
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990